Stocktoria
Eledon Pharmaceuticals, Inc. ELDN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-09-17
Eledon Pharmaceuticals, Inc. statistics & valuation
Market cap$291.8M
P / B3.6×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -27.0% | -20.4% | -130.8% | -94.8% | -20.2% |
| Return on equity | -56.3% | -57.9% | 240.4% | -104.5% | -21.0% |
| Current ratio | 7.40 | 12.42 | 14.41 | 9.19 | 20.07 |
Source: SEC EDGAR filings · CIK 0001404281 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.